A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2723823
The present invention provides conjugates of cytokines and targeting peptides that is able to bind to a receptor expressed on tumor-associated vessels or to a component of the extracellular matrix associated to the tumor vessels, for treatment of malignant pleural mesothelioma. In particular, the invention provides conjugates comprising the cytokine TNF linked to a peptide containing the NGR motif. The invention further provides pharmaceutical compositions comprising such conjugate and pharmaceutical formulations comprising conjugates dissolved in appropriate buffers.
La présente invention concerne des conjugués de cytokines et de peptides de ciblage capables de se lier à un récepteur exprimé sur les vaisseaux irriguant les tumeurs ou sur une composante de matrice extracellulaire associée aux vaisseaux tumoraux, dans le cadre du traitement du mésothéliome malin de la plèvre. Linvention porte en particulier sur des conjugués comprenant la cytokine TNF liée à un peptide contenant le motif NRG. Linvention concerne en outre des compositions pharmaceutiques contenant de tels conjugués et des formulations pharmaceutiques renfermant lesdits conjugués dissous dans des tampons appropriés.
Bordignon Claudio
Lambiase Antonio
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Molmed S.p.a.
LandOfFree
Conjugates for the treatment of mesothelioma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugates for the treatment of mesothelioma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugates for the treatment of mesothelioma will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2076345